130 related articles for article (PubMed ID: 17962610)
1. Activation of growth factor receptors in esophageal cancer--implications for therapy.
Ekman S; Bergqvist M; Heldin CH; Lennartsson J
Oncologist; 2007 Oct; 12(10):1165-77. PubMed ID: 17962610
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies for esophageal cancer.
Tew WP; Kelsen DP; Ilson DH
Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
[TBL] [Abstract][Full Text] [Related]
3. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
4. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.
Abdel-Latif MM; Kelleher D; Reynolds JV
J Surg Res; 2009 May; 153(1):172-80. PubMed ID: 18533190
[TBL] [Abstract][Full Text] [Related]
5. TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells.
Wang ZG; Fukazawa T; Nishikawa T; Watanabe N; Sakurama K; Motoki T; Takaoka M; Hatakeyama S; Omori O; Ohara T; Tanabe S; Fujiwara Y; Shirakawa Y; Yamatsuji T; Tanaka N; Naomoto Y
Oncol Rep; 2008 Dec; 20(6):1473-7. PubMed ID: 19020730
[TBL] [Abstract][Full Text] [Related]
6. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
7. The importance of growth factors for preimplantation embryo development and in-vitro culture.
Richter KS
Curr Opin Obstet Gynecol; 2008 Jun; 20(3):292-304. PubMed ID: 18460945
[TBL] [Abstract][Full Text] [Related]
8. Esophageal cancer: a review and update.
Layke JC; Lopez PP
Am Fam Physician; 2006 Jun; 73(12):2187-94. PubMed ID: 16836035
[TBL] [Abstract][Full Text] [Related]
9. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways.
Haarmann-Stemmann T; Bothe H; Abel J
Biochem Pharmacol; 2009 Feb; 77(4):508-20. PubMed ID: 18848820
[TBL] [Abstract][Full Text] [Related]
10. Modulation of growth factor action by the extracellular matrix.
Oehrl W; Panayotou G
Connect Tissue Res; 2008; 49(3):145-8. PubMed ID: 18661330
[TBL] [Abstract][Full Text] [Related]
11. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
12. Esophageal cancer: current and emerging therapy modalities.
Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Cap43 is associated with malignant status of esophageal cancer.
Sohda M; Mochida Y; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Masuda N; Ono M; Kuwano M; Kuwano H
Anticancer Res; 2009 Apr; 29(4):965-70. PubMed ID: 19414333
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for oesophageal cancer: an overview.
Syrigos KN; Zalonis A; Kotteas E; Saif MW
Cancer Metastasis Rev; 2008 Jun; 27(2):273-88. PubMed ID: 18224295
[TBL] [Abstract][Full Text] [Related]
15. Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.
Gielen SC; Santegoets LA; Kühne LC; Van Ijcken WF; Boers-Sijmons B; Hanifi-Moghaddam P; Helmerhorst TJ; Blok LJ; Burger CW
Reprod Sci; 2007 Oct; 14(7):646-54. PubMed ID: 18000226
[TBL] [Abstract][Full Text] [Related]
16. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and gene expression in esophageal cancer.
Xu XC
Methods Mol Biol; 2009; 471():335-60. PubMed ID: 19109788
[TBL] [Abstract][Full Text] [Related]
18. Compartmentalization of growth factor receptor signalling.
Hoeller D; Volarevic S; Dikic I
Curr Opin Cell Biol; 2005 Apr; 17(2):107-11. PubMed ID: 15780584
[TBL] [Abstract][Full Text] [Related]
19. Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.
Capdevila J; Ramos FJ; Macarulla T; Elez E; Ruiz-Echarri M; Perez-Garcia J; Tabernero J
Curr Opin Oncol; 2009 Jul; 21(4):374-80. PubMed ID: 19412097
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
